Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Invivo Therapeutics Holdings Corp (NQ: NVIV ) N/A UNCHANGED Last Price Updated: 4:00 PM EST, Feb 12, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about Invivo Therapeutics Holdings Corp InVivo Therapeutics Announces Topline Data from Pivotal INSPIRE 2.0 Study in Acute Spinal Cord Injury March 09, 2023 From InVivo Therapeutics Holdings Corp. Via Business Wire InVivo Therapeutics Announces Closing of $9 Million Registered Direct and Private Placement Offerings, Priced At-the-Market Under Nasdaq Rules October 11, 2022 From InVivo Therapeutics Holdings Corp. Via Business Wire InVivo Therapeutics Announces $9 Million Registered Direct and Private Placement Offerings, Priced At-the-Market Under Nasdaq Rules October 07, 2022 From InVivo Therapeutics Holdings Corp. Via Business Wire InVivo Therapeutics Announces Participation at Upcoming H.C. Wainwright 24th Annual Global Investment Conference September 09, 2022 From InVivo Therapeutics Holdings Corp. Via Business Wire InVivo Therapeutics Announces Appointment of Heather M. Hamel as Chief Legal Officer and General Counsel July 13, 2022 From InVivo Therapeutics Holdings Corp. Via Business Wire InVivo Therapeutics Announces Publication of 12- and 24-month Data for INSPIRE 1.0 Study in Peer-Reviewed Neurosurgery June 08, 2022 From InVivo Therapeutics Holdings Corp. Via Business Wire InVivo Therapeutics Announces Completion of Enrollment for the INSPIRE 2.0 Acute Spinal Cord Injury Study June 02, 2022 From InVivo Therapeutics Holdings Corp. Via Business Wire InVivo Therapeutics Announces Reverse Stock Split April 14, 2022 From InVivo Therapeutics Holdings Corp. Via Business Wire InVivo Therapeutics Announces Participation at Upcoming H.C. Wainwright BioConnect Conference January 06, 2022 From InVivo Therapeutics Holdings Corp. Via Business Wire InVivo Therapeutics Announces Participation at Upcoming H.C. Wainwright Annual Global Investment Conference September 09, 2021 From InVivo Therapeutics Holdings Corp. Via Business Wire InVivo Therapeutics Announces 75% Target Enrollment Achieved for the INSPIRE 2.0 Spinal Cord Injury Study September 08, 2021 From InVivo Therapeutics Holdings Corp. Via Business Wire InVivo Therapeutics Announces FDA Acceptance of Preclinical Module in Support of Company’s Complete HDE Submission July 13, 2021 From InVivo Therapeutics Holdings Corp. Via Business Wire InVivo Therapeutics Urges All Stockholders to Vote at the 2021 Annual Meeting to Be Held on Friday July 16, 2021 July 06, 2021 From InVivo Therapeutics Holdings Corp. Via Business Wire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.